Limits...
Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]

View Article: PubMed Central

No MeSH data available.


Related in: MedlinePlus

Forest plots of direct estimates for anti-TNFs versus placebo comparisons.Abbreviations: anti-TNF, anti-tumor necrosis factor; HAQ, Health Assessment Questionnaire; PASI, Psoriasis Area and Severity Index; PsARC, Psoriatic Arthritis Response Criteria.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3921085&req=5

f2-btt-8-057: Forest plots of direct estimates for anti-TNFs versus placebo comparisons.Abbreviations: anti-TNF, anti-tumor necrosis factor; HAQ, Health Assessment Questionnaire; PASI, Psoriasis Area and Severity Index; PsARC, Psoriatic Arthritis Response Criteria.

Mentions: On page 421, Figure 2, the relative risk for golimumab versus placebo for the PsARC response was incorrectly listed as 2.45, and should be 3.45. The mean difference for etanercept versus placebo for the PASI response was incorrectly listed as 2.13, and should be 3.13. The x-axis of the PASI forest plot was incorrectly labeled with mean difference values of 1, 2, 3 and 4. The correct values are 3, 6, 9 and 12.


Anti-tumor necrosis factor (TNF) drugs for the treatment of psoriatic arthritis: an indirect comparison meta-analysis [Corrigendum]
Forest plots of direct estimates for anti-TNFs versus placebo comparisons.Abbreviations: anti-TNF, anti-tumor necrosis factor; HAQ, Health Assessment Questionnaire; PASI, Psoriasis Area and Severity Index; PsARC, Psoriatic Arthritis Response Criteria.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3921085&req=5

f2-btt-8-057: Forest plots of direct estimates for anti-TNFs versus placebo comparisons.Abbreviations: anti-TNF, anti-tumor necrosis factor; HAQ, Health Assessment Questionnaire; PASI, Psoriasis Area and Severity Index; PsARC, Psoriatic Arthritis Response Criteria.
Mentions: On page 421, Figure 2, the relative risk for golimumab versus placebo for the PsARC response was incorrectly listed as 2.45, and should be 3.45. The mean difference for etanercept versus placebo for the PASI response was incorrectly listed as 2.13, and should be 3.13. The x-axis of the PASI forest plot was incorrectly labeled with mean difference values of 1, 2, 3 and 4. The correct values are 3, 6, 9 and 12.

View Article: PubMed Central

No MeSH data available.


Related in: MedlinePlus